Those eligible for the extra shot would include adults over 65 and others at high risk — the same groups now eligible for a Pfizer-BioNTech boostThose eligible for the extra shot would include adults over 65 and others at high risk — the same groups now eligible for a Pfizer-BioNTech boostModerna Inc, Food and Drug Administration, Vaccination and Immunization, Coronavirus (2019-nCoV), United States, ElderlyRead More
